On the Possibility of Using Succinate in Hypoxia Developing in COVID-19
Aim. To provide a rationale for the feasibility of using the succinate-containing drugs to treat hypoxia associated with COVID-19 based on the analysis of experimental and clinical studies.Materials and methods. 84 Russian and international literature sources concerning the pathogenesis of COVID-19...
Saved in:
Main Authors: | Yu. P. Orlov, N. V. Govorova, O. V. Korpacheva, V. V. Afanasyev, I. A. Khilenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2021-07-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/2084 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Prospects of Succinates’ Use under Hypoxic Conditions in COVID-19
by: Yu. Р. Orlov, et al.
Published: (2021-05-01) -
Dexamethasone in Treatment of Comorbid SARS-CoV-2 Patients Aged over 50 Years with Lung Injury over 50 %
by: O. Yu. Zolnikova, et al.
Published: (2021-10-01) -
<i>Сlostridium difficile</i> Infection in a COVID-19 Patient
by: A. A. Timofeeva, et al.
Published: (2021-10-01) -
Outbreak of Anthrax in the Yamalo-Nenets Autonomous District in 2016, Epidemiological Peculiarities
by: A. Yu. Popova, et al.
Published: (2016-12-01) -
Peripheral nerve sheath malignancy with multiple metastasis: a rare clinical case
by: S. S. Todorov, et al.
Published: (2021-02-01)